Condition

Infections, Human Immunodeficiency Virus and Hepatitis

ClinicalTrials.gov condition label

Clinical trials4

Recruiting0

Common interventions9

Lead sponsors shown1

Clinical trials

4 shown

Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female SubjectsNCT02159131 · 2014-08-01

COMPLETED

Relative Bioavailability Study of GSK1265744 FormulationsNCT01648257 · 2012-08-01

COMPLETED

Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.NCT01467518 · 2011-12-01

COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult SubjectsNCT01467531 · 2011-11-01

COMPLETED

Common interventions

DolutegravirDRUG2GSK1265744DRUG2Ethinyl EstadiolDRUG1GSK1265744 Free Acid Micronized CapsulesDRUG1GSK1265744 Free Acid Nanomilled CapsulesDRUG1GSK1265744 Na Salt TabletsDRUG1LevonorgestrelDRUG1MethadoneDRUG1RlipivirineDRUG1

Leading sponsors

ViiV Healthcare4

Trial status mix

COMPLETED4

Phase mix

PHASE14

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.